Relugolix combination therapy in symptomatic adenomyosis and uterine fibroids: a case series

Objective To evaluate the clinical efficacy and safety of a once-daily oral fixed-dose combination of relugolix 40 mg, estradiol 1 mg, and norethisterone acetate 0.5 mg in women with symptomatic adenomyosis coexisting with uterine fibroids.Methods This case series included six women with uterine fib...

Descrición completa

Detalles Bibliográficos

Principais autores:	Stefania Saponara, Maurizio Nicola D'Alterio, Stefano Di Michele, Caterina Chilà, Antonio Maiorana, Michele Vignali, Ludovico Muzii, Stefano Angioni
Formato:	Artigo
Idioma:	Inglês
Publicado:	Taylor & Francis Group 2026-12-01
Series:	Gynecological Endocrinology
Assuntos:	Adenomyosis leiomyoma relugolix gonadotropin-releasing hormone menorrhagia
Acceso en liña:	https://www.tandfonline.com/doi/10.1080/09513590.2026.2659439
Tags:	Engadir etiqueta Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!